Just my silly thoughtsHey all, if you check my posting history you'll find that I took a position with TBP @ $0.75 per share. I took that position after some careful thought, and felt like it was a solid price to get in. I truly felt that was as close to the bottom that I would see. Now I don't like to look at my portfolio on a day to day basis. But I checked in about a week and a bit ago, and found that I had lost $0.14 per share after holding for about a month and a half. Now my calculator tells me that's a ~18% loss. Fast forward to today, and here we are at $0.71. That's still cheaper than what I literally spent all my free investment money on, and honestly, I'm a bit surprised. Do I think the price will go down? I actually do think we will still see 0.60s again, but that's probably due to low volume in between news releases, and due to impulse selling of people who recently bought in the 0.70s but have quickly given up to ride another stock surge. But I'm absolutely not saying that I'm disappointed in the timing of my investment. I think the current SP is not reflecting some fairly substantial and inevitable milestones. And the biggest inevitable milestone is when TBP obtains a DIN number for PPP001. And why it matters is applicable in two ways: 1) For Physicians who are hesitant to prescribe a drug without proper scientific studies, and 2) Insurance companies who (predominantly) won't cover the cost of a valid prescription drug. Consider this paragraph from a Huffington Post article: "In Canada, all authorized drug products, be they prescription or over-the-counter, are assigned a Drug Identification Number (DIN) by Health Canada. This computer-generated eight digit number is displayed on a products' packaging and uniquely identifies the drug as having been evaluated and authorized for sale in Canada. Physicians, pharmacists and the public rely on the DIN to verify information about a drug's characteristics, manufacturer, product name, active ingredient(s), strength, pharmaceutical form, and route of administration. In many ways, a DIN serves as Health Canada's seal of approval and it is what permits a manufacturer to legally market a drug in Canada. As far as consumers go, it lets users know that the product has undergone and passed a rigorous review and is, with proper dosage and administration, safe and suitable for treating a particular condition. As far as the sale of drugs goes in Canada, having a DIN is so important that, according to Health Canada, "A drug product sold in Canada without a DIN is not in compliance with Canadian law." and "If a product defined as a drug under the Food and Drugs Act is sold without a DIN, it is not in compliance with Canadian law and regulatory action will be taken." Funnily enough, medical marijuana does not have a DIN." Now I'm "down with the old crowd" as you'd say, and I'm aware of a few friends who fund their own pain management (if you catch my drift) due to the fact that their insurers won't fund it, even with a valid prescription. I'm also familiar with the fact that some insurers have indeed covered medical marijuana in some instances where they have been taken to court. But the vast majority of insurers are waiting for a DIN number to avoid the legal headaches of replacing medicines that are already being used. Here's another paragraph from beneplan.ca: "According to the Canadian Medical Cannabis Industry, the estimated average prescription cost for medical marijuana is $7.50 per day, good for about one gram of medical marijuana. This is below $12.25 dollar per day for Sativex, a medication prescribed for patients suffering with similar conditions." Does anyone here know who manufactors Sativex? A company by the name of GW Pharmaceuticals. Here's a couple of paragraphs about Sativex, and the legality of it: "This medication contains two ingredients: tetrahydrocannabinol (THC) and cannabidiol (CBD). These ingredients belong to the family of medications known as cannabinoids and are extracted from the Cannabis sativa (hemp) plant. This medication is used to treat pain. Although it is not known exactly how THC and CBD work to relieve nerve pain, it is thought to work by mimicking natural pain relievers called cannabinoids that are released in the body. Delta-9-tetrahydrocannabinol (THC) - cannabidiol (CBD) has also been granted a notice of compliance with conditions (NOC/c) by Health Canada to reduce the nerve pain that is also associated with MS and to treat moderate-to-severe pain in advanced cancer, when the highest doses of other pain relievers do not provide adequate pain relief. This means that Health Canada has approved this medication to be marketed based on promising evidence of effectiveness, but additional results of studies are needed to verify its effectiveness. An NOC/c is used to allow access to products that are used to treat or prevent serious, life-threatening, or severely debilitating illness." So basically, the drug that TBP is aiming to replace with DIN approved, and cheaper PPP001 is (drum roll please)...Sativex! A drug that is being sold by a company trading at ~$109 per share! Even if TBP sells one gram of PPP001 herb at $10 a gram, they are still undercutting the weed extract Sativex. Both insurance companies AND consumer win here, because it's 1) a cheaper product that's locally manufactured (and hence, taxed) and 2) it's a more natural product. Oh man, I got really sleepy by the end of this post, but all I'm saying is, don't sleep on TBP.